Predictive effect of urinary concentrating ability and hemagglutinating antibody titer upon response to antimicrobial therapy in bacteriuria of pregnancy.
D000906:Antibodies / Q000032:analysis*; D001437:Bacteriuria / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D002986:Clinical Trials as Topic; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007671:Kidney Concentrating Ability; D007752:Obstetric Labor, Premature / Q000209:etiology; D010919:Placebos; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011379:Prognosis; D011704:Pyelonephritis / Q000175:diagnosis; D011859:Radiography; D013449:Sulfonamides / Q000627:therapeutic use*; D014227:Triazines / Q000627:therapeutic use*
D000906:Antibodies; D010919:Placebos; D013449:Sulfonamides; D014227:Triazines